DOI QR코드

DOI QR Code

Cyclosporin A Inhibits Albumin Synthesis in Huh7 Cells

  • Jeon, Youn-Joo (Bupyoung Internal Medicine Clinic) ;
  • Kim, Yong-Soo (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea School of Medicine)
  • Published : 2011.09.01

Abstract

Background/Aims: Hypoalbuminemia occurs frequently in renal transplant recipients immediately after renal transplantation. We studied the regulation of hepatic albumin synthesis by cyclosporin A (CsA) in Huh7 cells. Methods: Huh7 cells were incubated with various concentrations of CsA for 4, 8, 16, and 24 hours. Albumin was measured in Huh7 cell-conditioned medium by sandwich enzyme-linked immunosorbent assay and Western blot. Albumin mRNA expression was analyzed by Northern blotting in CsA-treated cells. Results: CsA ($10^{-7}-10^{-4}$ M) inhibited albumin synthesis in Huh7 cells in a dose- dependent manner. A Western blot analysis for albumin in the conditioned medium released from CsA-treated ($10^{-7}-10^{-5}$ M) cells also showed significant inhibition of albumin synthesis in a dose-dependent manner. Vehicle (olive oil) did not affect albumin synthesis. In contrast, a Northern blot analysis revealed no inhibition of albumin mRNA expression by CsA at any time point from 1-24 hours, indicating that the inhibition of albumin synthesis occurred at the translational level. Conclusions: Our results suggest that inhibition of hepatic albumin synthesis by high dose CsA contributes to the hypoalbuminemia in renal transplant recipients.

Keywords

References

  1. Dawidson IJ, Ar'Rajab A. Perioperative fluid and drug therapy during cadaver kidney transplantation. Clin Transpl 1992:267-284.
  2. Mouridsen HT, Faber M. Accumulation of serum-albumin at the operative wound site as a cause of postoperative hypoalbuminaemia. Lancet 1966;2:723-725.
  3. Werner M, Odenthal D. Serum protein changes after gastrectomy as a model of acute phase reaction. J Lab Clin Med 1967;70:302-310.
  4. Backman L, Appelkvist EL, Ringden O, Dallner G. Effects of cyclosporine A on hepatic protein synthesis. Transplant Proc 1988;20(3 Suppl 3):853-858.
  5. Vine W, Billiar T, Simmons R, Bowers LD. Cyclosporineinduced hepatotoxicity: a microassay by hepatocytes in tissue culture. Transplant Proc 1988;20(3 Suppl 3):859-862.
  6. Buss WC, Stepanek J, Bennett WM. Proposed mechanism of cyclosporine toxicity: inhibition of protein synthesis. Transplant Proc 1988;20(3 Suppl 3):863-867.
  7. Rothschild MA, Oratz M, Schreiber SS. Albumin synthesis: 1. N Engl J Med 1972;286:748-757. https://doi.org/10.1056/NEJM197204062861404
  8. Rothschild MA, Oratz M, Schreiber SS. Albumin metabolism. Gastroenterology 1973;64:324-337.
  9. Edwards K, Fleischer B, Dryburgh H, Fleischer S, Schreiber G. The distribution of albumin precursor protein and albumin in liver. Biochem Biophys Res Commun 1976;72:310-318. https://doi.org/10.1016/0006-291X(76)90995-5
  10. Kawai HF, Kaneko S, Honda M, Shirota Y, Kobayashi K. alphafetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Hepatology 2001;33:676-691. https://doi.org/10.1053/jhep.2001.22500
  11. Vraetz T, Ittel TH, van Mackelenbergh MG, Heinrich PC, Sieberth HG, Graeve L. Regulation of beta2-microglobulin expression in different human cell lines by proinflammatory cytokines. Nephrol Dial Transplant 1999;14:2137-2143. https://doi.org/10.1093/ndt/14.9.2137
  12. Masumoto A, Arao S, Otsuki M. Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology 1999;29:68-74. https://doi.org/10.1002/hep.510290146
  13. Trinder D, Zak O, Aisen P. Transferrin receptor-independent uptake of differic transferrin by human hepatoma cells with antisense inhibition of receptor expression. Hepatology 1996;23:1512-1520. https://doi.org/10.1002/hep.510230631
  14. Blair JT, Thomson AW, Whiting PH, Davidson RJ, Simpson JG. Toxicity of the immune suppressant cyclosporin A in the rat. J Pathol 1982;138:163-178. https://doi.org/10.1002/path.1711380206
  15. Kruger B, Ulrich C, Kohler H, Riegel W. Different effects of cyclosporine or tacrolimus on hepatocyte acute phase proteins. Transplant Proc 1998;30:989-990. https://doi.org/10.1016/S0041-1345(98)00121-3
  16. Bergstrom J. Nutrition and mortality in hemodialysis. J Am Soc Nephrol 1995;6:1329-1341.
  17. Lodish HF, Kong N. Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. J Biol Chem 1991;266:14835-14838.
  18. Wagner O, Schreier E, Heitz F, Maurer G. Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab Dispos 1987;15:377-383.
  19. Li Y, Liu FY, Liu ZH, et al. Effect of tacrolimus and cyclosporine A on suppression of albumin secretion induced by inflammatory cytokines in cultured human hepatocytes. Inflamm Res 2006;55:216-220. https://doi.org/10.1007/s00011-006-0074-0
  20. Mogielnicki RP, Waldmann TA, Strober W. Renal handling of low molecular weight proteins. I. L-Chain metabolism in experimental renal disease. J Clin Invest 1971;50:901-909. https://doi.org/10.1172/JCI106562
  21. Katz J, Bonorris G, Sellers AL. albumin metabolism in aminonucleoside nephrotic rats. J Lab Clin Med 1963;62:910-934.
  22. Bourdeau JE, Carone FA, Ganote CE. Serum albumin uptake in isolated perfused renal tubules: quantitative and electron microscope radioautographic studies in three anatomical segments of the rabbit nephron. J Cell Biol 1972;54:382-398. https://doi.org/10.1083/jcb.54.2.382

Cited by

  1. Therapeutic Efficacy of Thymoquinone and Selenium Against Cyclosporine A Nephrotoxicity in Rats vol.10, pp.2, 2011, https://doi.org/10.3923/jpt.2015.60.70
  2. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis vol.8, pp.13, 2020, https://doi.org/10.14814/phy2.14482
  3. Simultaneous Detection of Human Serum Albumin and Sulfur Dioxide in Living Cells Based on a Catalyzed Michael Addition Reaction vol.92, pp.24, 2011, https://doi.org/10.1021/acs.analchem.0c03806